As of Apr 17
| -0.08 / -3.28%|
The 3 analysts offering 12-month price forecasts for Synthetic Biologics Inc have a median target of 4.00, with a high estimate of 6.75 and a low estimate of 3.00. The median estimate represents a +69.49% increase from the last price of 2.36.
The current consensus among 3 polled investment analysts is to Buy stock in Synthetic Biologics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.